Connect with us
European Gaming Congress 2024

Artificial Intelligence

PremFina’s Art&Co. Disperses Funds to ICU StepsArt&Co. (“Art&Co.”), an initiative connecting the worlds of art, finance and support groups brings continued relief to COVID-19 victims. It is backed by PremFina (“PremFina” or the “Company”), the U.K.’s first venture capital backed alternative insurance premium finance company. Art&Co. addresses a stark statistic that only 3% of natural disasters are covered by Insurance. Funds raised from the online auction comprised of more than 200 pieces, supported frontline charities and NGOs providing healthcare, food, medicines, and guidance to those affected by the contagion. Curated artwork of themes being contemplated by societies worldwide: community, celebrities, depression, domestic violence, environment, health, loneliness, mortality, nature, science, and spirituality. Along with more than 30 emerging artists struggling financially during lockdown, there were also donated works of art from Pablo Picasso, Salvador Dali, Andy Warhol, and Jeff Koons. Art&Co. has had press in Bloomberg, Business Insider, Evening Standard, The Independent, 1883, The Art Newspaper, The Resident, BBC World Radio, Eastern Eye, Gulf Today and many more. Art&Co. is a charitable project backed by PremFina and InsurAid. InsurAid is an industry movement that’s “unconditionally supporting the uninsurable” during such times of unforeseen catastrophes, that insurance companies are virtually unable to predict, let alone calculate and price for the risk of potential causal loss. “Medical patients that are in critical care oftentimes don’t fully get the physical and mental support they need after they leave hospital. This lack of post hospital-care leaves individuals feeling helpless and frequently does not allow them to fully recover. ICU Steps is a fantastic support organisation which provides this much needed care for recovering patients which extends and betters their overall wellbeing.” Founder of Art&Co. and CEO of PremFina, Bundeep Singh Rangar This charitable art auction encourages both individuals and corporates to participate and bid on one-of-a-kind art representing themes connected to these trying times, such as health, nature, and spirituality. The funds raised will mostly go to frontline organisations, with the remainder going toward more than 30 freelance artists who are contributing their work and otherwise unable to sell art due to the lockdown. The artwork purchased will become a tangible display of their efforts to support those challenged in the years to come and can be used as a part of their Corporate Social Responsibility goals. ICU Steps, Peter Gibbs said “Whatever the reason for a patient’s admission to ICU, critical illness can be a traumatic experience. We try to make sure that surviving isn’t so traumatic. With the help of former patients, relatives, healthcare professionals and fundraising events like Art&Co., we’re able to help ICU survivors on their long road to recovery after leaving intensive care. Though our network of peer support groups, the provision of patient information and work with ICU researchers on topics that matter most to patients, we try to make the road to recovery as smooth as we can. Critical care may save our lives, but we need support and rehabilitation to give those lives back to us.” The auction supports Art&Co.’s mandate to support those affected by humanitarian disasters, public health and safety crises, focusing on events for which insurance is scarce or unavailable. London-based insurtech firm PremFina’s shareholders include global investors Rakuten Capital, the investment arm of Japan’s Rakuten, a global leader in e-commerce and fintech, the UK’s Draper Esprit Plc, backed by Silicon Valley billionaire Tim Draper, Thomvest Ventures – the venture capital firm of Peter Thomson, whose family is known for its namesake Thomson Reuters Corp., Emery Capital, US-based Rubicon Venture Capital, London-based Talis Capital and the company’s founder. COVID-19 facts regarding ICU patients and the creative industry: Rates of delirium for patients in the intensive care unit (ICU) have skyrocketed in the coronavirus disease 2019 (COVID-19) pandemic. https://www.ajmc.com/view/risks-of-developing-delirium-in-icu-patients-with-covid-19

Published

on

 

Art&Co. (“Art&Co.”), an initiative connecting the worlds of art, finance and support groups brings continued relief to COVID-19 victims. It is backed by PremFina (“PremFina” or the “Company”), the U.K.’s first venture capital backed alternative insurance premium finance company.

Art&Co. addresses a stark statistic that only 3% of natural disasters are covered by Insurance. Funds raised from the online auction comprised of more than 200 pieces, supported frontline charities and NGOs providing healthcare, food, medicines, and guidance to those affected by the contagion.

Curated artwork of themes being contemplated by societies worldwide: community, celebrities, depression, domestic violence, environment, health, loneliness, mortality, nature, science, and spirituality. Along with more than 30 emerging artists struggling financially during lockdown, there were also donated works of art from Pablo Picasso, Salvador Dali, Andy Warhol, and Jeff Koons.

Art&Co. has had press in Bloomberg, Business Insider, Evening Standard, The Independent, 1883, The Art Newspaper, The Resident, BBC World Radio, Eastern Eye, Gulf Today and many more.

Advertisement
Stake.com

Art&Co. is a charitable project backed by PremFina and InsurAid. InsurAid is an industry movement that’s “unconditionally supporting the uninsurable” during such times of unforeseen catastrophes, that insurance companies are virtually unable to predict, let alone calculate and price for the risk of potential causal loss.

“Medical patients that are in critical care oftentimes don’t fully get the physical and mental support they need after they leave hospital. This lack of post hospital-care leaves individuals feeling helpless and frequently does not allow them to fully recover. ICU Steps is a fantastic support organisation which provides this much needed care for recovering patients which extends and betters their overall wellbeing.” Founder of Art&Co. and CEO of PremFina, Bundeep Singh Rangar

This charitable art auction encourages both individuals and corporates to participate and bid on one-of-a-kind art representing themes connected to these trying times, such as health, nature, and spirituality. The funds raised will mostly go to frontline organisations, with the remainder going toward more than 30 freelance artists who are contributing their work and otherwise unable to sell art due to the lockdown. The artwork purchased will become a tangible display of their efforts to support those challenged in the years to come and can be used as a part of their Corporate Social Responsibility goals.

ICU Steps, Peter Gibbs said “Whatever the reason for a patient’s admission to ICU, critical illness can be a traumatic experience. We try to make sure that surviving isn’t so traumatic. With the help of former patients, relatives, healthcare professionals and fundraising events like Art&Co., we’re able to help ICU survivors on their long road to recovery after leaving intensive care. Though our network of peer support groups, the provision of patient information and work with ICU researchers on topics that matter most to patients, we try to make the road to recovery as smooth as we can. Critical care may save our lives, but we need support and rehabilitation to give those lives back to us.”

The auction supports Art&Co.’s mandate to support those affected by humanitarian disasters, public health and safety crises, focusing on events for which insurance is scarce or unavailable.

Advertisement
Stake.com

London-based insurtech firm PremFina’s shareholders include global investors Rakuten Capital, the investment arm of Japan’s Rakuten, a global leader in e-commerce and fintech, the UK’s Draper Esprit Plc, backed by Silicon Valley billionaire Tim Draper, Thomvest Ventures – the venture capital firm of Peter Thomson, whose family is known for its namesake Thomson Reuters Corp., Emery Capital, US-based Rubicon Venture Capital, London-based Talis Capital and the company’s founder.

COVID-19 facts regarding ICU patients and the creative industry:

Rates of delirium for patients in the intensive care unit (ICU) have skyrocketed in the coronavirus disease 2019 (COVID-19) pandemic. https://www.ajmc.com/view/risks-of-developing-delirium-in-icu-patients-with-covid-19

Artificial Intelligence

KMS Lighthouse and lastminute.com Triumph with a Double Win at the Global Sourcing Association (GSA) 2024 Awards

Published

on

kms-lighthouse-and-lastminute.com-triumph-with-a-double-win-at-the-global-sourcing-association-(gsa)-2024-awards

TEL AVIV, Israel, June 17, 2024 /PRNewswire/ — KMS Lighthouse, a global leader in knowledge management, is proud to announce its remarkable achievement of winning two prestigious awards with lastminute.com at the Global Sourcing Association (GSA) 2024 Awards. The brands were honored in the following categories:

Retail Programme of the Year: lastminute.com and KMS Lighthouse LimitedTechnology Enabled Programme of the Year (Automation/AI): lastminute.com and KMS Lighthouse LimitedKMS Lighthouse was also a finalist in the Service Provider of the Year category.
The awards were presented on June 11, 2024, at a glittering ceremony held at Richmond Hill Hotel, as part of the GSA Festival of Sourcing. Celebrating its 21st year, the GSA Awards recognize organizations that demonstrate exceptional best practices in strategic sourcing.
Sagi Eliyahu, CEO of KMS Lighthouse Limited commented “We are absolutely delighted to have won these two esteemed awards. This recognition underscores the tireless dedication and innovation of our teams in delivering exceptional knowledge management solutions to our clients. I would like to extend my heartfelt gratitude to our partners at lastminute.com. The synergy and true partnership we have formed exemplify the collaborative spirit needed to drive outstanding results.”
“We are thrilled to celebrate these award wins with KMS Lighthouse,” said Walter Di Lello, Knowledge Manager & Procedure Team Leader at lastminute.com. “This achievement is a testament to the hard work and dedication of both our teams. The collaborative partnership approach we have fostered with KMS Lighthouse has been pivotal in delivering innovative and impactful solutions. Thank you to everyone involved for their relentless commitment and excellence.”
This double accolade highlights KMS Lighthouse’s unwavering commitment to excellence, innovation, and effective collaboration. The successful partnership with lastminute.com has not only enhanced the retail sector’s capabilities but also set new standards in automation and AI-driven solutions.
About KMS Lighthouse:
KMS Lighthouse is a global leader in knowledge management solutions, providing innovative platforms that enhance organizational knowledge sharing and decision-making. Through advanced AI and automation technologies, KMS Lighthouse enables businesses to improve customer service, streamline operations, and achieve higher efficiency.
About lastminute.com
lastminute.com is the European Travel-Tech leader in Dynamic Holiday Packages. Our mission is to simplify, personalise, and enhance our customers’ travel experience by leveraging technology. Thanks to the iconic brand lastminute.com and a rich portfolio of vertical brands, we meet the most diverse needs of travellers across the entire holiday experience. As one of the few fully licensed European tour operators, we offer unlimited real-time travel combinations thanks to our proprietary Dynamic Holiday Packaging engine, providing additional customer protection and exclusive deals. lastminute.com N.V. is a publicly traded company listed under the ticker symbol, LMN on the SIX Swiss Exchange.
Media Contact:KMS Lighthouse [email protected] [email protected]://www.linkedin.com/company/kms-lighthouse/https://kmslh.com/

View original content:https://www.prnewswire.co.uk/news-releases/kms-lighthouse-and-lastminutecom-triumph-with-a-double-win-at-the-global-sourcing-association-gsa-2024-awards-302174249.html

Continue Reading

Artificial Intelligence

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

Published

on

cluepoints-continues-‘turning-artificial-intelligence-into-human-intelligence’-by-launching-two-new-innovations

Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024
KING OF PRUSSIA, Pa., June 17, 2024 /PRNewswire/ — CluePoints, provider of leading statistical and AI-driven software solutions, will unveil two of its latest advanced, deep learning technology innovations at the DIA Global Annual Meeting 2024. Both solutions deliver groundbreaking enterprise platform transformations providing Sponsors and CROs with a smarter way to conduct clinical research and detect and manage risks that could impact clinical trial outcomes.

Taking RBQM to a new level, CluePoints’ Site Profile & Oversight Tool (SPOT) delivers adaptive site monitoring, enabling teams to swiftly pinpoint anomalies and translate insights into strategies and actions. Sponsors and CROs can improve their ability to evaluate the performance of clinical trial sites and adjust site visit plans more effectively and efficiently while accurately balancing risk and resource workload.
Further streamlining processes, CluePoints’ Intelligent Medical Coding solution harnesses advanced deep learning technology to enhance the accuracy and efficiency of coding in clinical trials. It seamlessly integrates with existing systems to offer precise, AI-generated coding suggestions, drastically reducing the need for manual dictionary searches and costly coding reviews, freeing up valuable resources and ensuring uniformity across all coded data.
Andy Cooper, CEO of CluePoints, said: “DIA offers the perfect opportunity to share with the industry our latest disruptive and innovative solutions that address key challenges within traditional clinical research methods. Unveiling two new products that leverage next generation AI will transform how CluePoints is viewed in the industry, as we enhance our enterprise-wide solutions to reach new levels of accuracy and efficiency to both improve clinical trial performance and deliver greater insights to further mitigate risk. Our early adopters are already raving about how valuable they are finding both product offerings and we are excited to showcase how they will shape future processes and embody our brand promise to ‘turn artificial intelligence into human intelligence.”
With over 9,500 users engaged with CluePoints’ enterprise platform, to date over 1,600 studies have been de-risked and over 142,000 issues detected.
Visitors to the CluePoints’ DIA Global exhibition booth #1301 will have the opportunity to meet with subject matter experts and see demonstrations of both new platform solutions.
CluePoints also invites DIA attendees to join them at 3pm on Tuesday, June 18th, for a special toast at their booth to celebrate the latest innovations.  
To learn more about CluePoints’ award-winning solutions, please visit www.cluepoints.com.
About CluePoints
CluePoints is the premier Risk-Based Quality Management (RBQM) and Data Quality Oversight Software provider. We are leveraging the potential of artificial intelligence using advanced statistics and machine learning to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA, EMA, and ICH E6 (R2), CluePoints is deployed to support central and on-site monitoring, medical review, quality risk management and to drive a holistic Risk-Based strategy in all trials. Coupled with thought leadership and consulting expertise to aid pre-study risk assessment, identification of risk controls and solution implementation, you now have everything you need to adhere with global regulatory guidance. The result is positive clinical development outcomes, increased operational efficiency, lower costs and reduced regulatory submission risk as part of the industry paradigm shift to RBQM.
 

View original content:https://www.prnewswire.co.uk/news-releases/cluepoints-continues-turning-artificial-intelligence-into-human-intelligence-by-launching-two-new-innovations-302174137.html

Continue Reading

Artificial Intelligence

ComplyCube Launches Trust Center with the Most Complete Compliance Posture in the Market

Published

on

complycube-launches-trust-center-with-the-most-complete-compliance-posture-in-the-market

LONDON, June 17, 2024 /PRNewswire/ — ComplyCube, a RegTech100 global leader in identity verification and compliance solutions, proudly announces the launch of its comprehensive Trust Center. This new initiative emphasizes ComplyCube’s unrivaled compliance posture, redefining security and privacy for IDV, KYC, and AML platforms. With over fifty continuously monitored controls, the AI-powered SaaS leads the way in ensuring clients stay ahead of international regulations and standards.

The Trust Center provides real-time updates on security measures, compliance statuses, and operational transparency, empowering clients to meet regulatory requirements confidently and allowing them to view ComplyCube’s compliance posture on demand. This platform is engineered to enhance transparency, build trust, and streamline compliance processes for organizations worldwide.
ComplyCube unveils its unrivaled compliance posture, redefining security and privacy for IDV, KYC, and AML platforms. With over fifty continuously monitored controls, ComplyCube leads the way in ensuring clients stay ahead of international regulations and standards.
Key Features of the Trust Center:
Real-Time Compliance Dashboard: Live updates on compliance metrics and security statuses.Comprehensive Resource Hub: Access to essential documents, certifications, and regulatory guidelines.Incident Reporting and Tracking: Full transparency in reporting and monitoring security incidents.Tarek Nechma, CEO of ComplyCube, remarked, “The launch of the Trust Center marks a pivotal milestone in our mission to build trust at scale and deliver state-of-the-art compliance solutions. This platform will empower our clients to navigate the complexities of regulatory landscapes with confidence.”
Non-compliance costs are 2.71 times higher than the costs of maintaining or meeting compliance requirements. Another study indicates that companies with strong compliance programs can reduce incident costs by up to 30%. On top of this, 84% of businesses encounter compliance challenges that can lead to significant financial and reputational damage. ComplyCube’s Trust Center aims to further mitigate these risks by providing tools that help businesses maintain and improve their compliance posture.
Mohamed Alsalehi, CTO of ComplyCube, stated, “We design our systems to be compliant by design with the stringent laws and regulations. This proactive approach ensures our clients can meet and exceed compliance requirements effortlessly.”
Joshua Dent, Business & Partnerships Manager, added, “The Trust Center showcases ComplyCube’s adherence to a multitude of globally recognized standards and data protection regulations. Clients and partners can find answers to many of their data protection questions, view active controls, and request documents to fulfill due diligence. It’s fantastic to see this go live following our latest certifications, such as UK DIATF, ISO 9001, PAD Level 2, and ISO 27001:2022 upgrade.”
ComplyCube continues to set industry standards with its innovative solutions, and the Trust Center’s launch underscores its mission to support businesses in achieving compliance excellence.
For more information about the Trust Center, visit ComplyCube Trust Center.
About ComplyCubeComplyCube is a leading provider of identity verification and compliance solutions, helping organizations across various sectors secure their operations and meet regulatory requirements. With a focus on innovation and customer satisfaction, ComplyCube delivers reliable and efficient services that empower businesses to thrive in a complex regulatory environment.
About VantaVanta is a leading trust management platform that automates compliance and streamlines security reviews for SaaS businesses. It helps companies manage risk and prove security in real-time, ensuring adherence to global standards and data protection regulations. With Vanta’s Trust Center, businesses can efficiently manage compliance processes and demonstrate their commitment to security and trust.
 
Photo: https://mma.prnewswire.com/media/2440210/Complycube_launches_trust_center.jpgLogo: https://mma.prnewswire.com/media/2148485/4765606/ComplyCube_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/complycube-launches-trust-center-with-the-most-complete-compliance-posture-in-the-market-302174177.html

Continue Reading
Advertisement
Stake.com
Advertisement

Latest News

Trending